AI Image
FDA Announces Recall on Blood Pressure Medication-More Than 13,000 Bottles Affected Nationwide
Health.com • • health
Key Points:
- The FDA has issued a nationwide recall of over 13,000 bottles of chlorthalidone, a common blood pressure medication, due to failed dissolution specifications that may affect the drug's effectiveness.
- The recall, classified as Class II, indicates a low risk of serious health consequences but a potential for temporary or reversible effects.
- The affected product is chlorthalidone tablets (25 mg, 100 tablets per bottle) manufactured by Inventia Healthcare Limited, with batch code RISA24002 and expiration date April 2027.
- This recall follows a similar one in June involving more than 11,000 bottles from the same manufacturer for the same issue.
- Patients with the recalled medication are advised to consult their healthcare provider before making any changes to their medication, as stopping treatment abruptly may pose greater risks.
